Moderna, Inc. Common Stock MRNA
$174.38
+176.97%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 2026-08-07 | View → |
| 10-Q | 10-Q | 2026-07-31 | View → |
| 8-K | 8-K | 2026-07-31 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-10 | View → |
| 8-K | 8-K | 2026-07-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-07 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-17 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-29 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-29 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-29 | View → |
| 4 | 4 | 2026-05-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-18 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 10-Q | 10-Q | 2026-05-01 | View → |
| 8-K | 8-K | 2026-05-01 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-06 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-03-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-06 | View → |
| 8-K | 8-K | 2026-03-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $174.38
- Market Cap
- $25.14 billion
- 52-Week Range
- $22.28 – $176.66
- Average Volume
- 11.92 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.